EVOLVA HOLDING SA |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.946 CHF | -6.34% |
|
+0.42% | +31.39% |
| Apr. 15 | Evolva Shareholders Pass Resolutions to Revoke Liquidation, Delisting | MT |
| Mar. 26 | Evolva Secures Temporary Exemption from Listing Rules Amid Liquidation | MT |
Evolva Holding SA (Evolva) is a Switzerland-based biotechnology company reseaching, developing and commerzializing nature-based ingrendients. The activity of the Company is divided into two segments: technololgy platforms - combines biology with technology to produce nature-based ingredients; technology servises- provides tailored services to clients across industries. The Company is focused on developing and increase the yield and efficiency of the production of various ingredients.
Calendar
2024-08-21
- Q2 2024 Earnings Release (Projected)
Annual profits - Rate of surprise
| 1st Jan change | Capi. | |
|---|---|---|
| +31.39% | 7.46M | |
| +1.51% | 42.75B | |
| +8.57% | 41.34B | |
| +49.22% | 41.61B | |
| -12.36% | 26.59B | |
| +8.92% | 25.49B | |
| -25.13% | 18.12B | |
| +29.17% | 12.24B | |
| -3.12% | 11.76B | |
| +6.35% | 11B |
- Stock Market
- Equities
- EVE Stock
- Funds and ETFs Evolva Holding SA
